JOEL STEVEN BENTZ
Medical Practice in Salt Lake City, UT
License number
Pennsylvania MD055804L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Salt Lake City, UT 84121
Pennsylvania
Pennsylvania
Personal information
See more information about JOEL STEVEN BENTZ at radaris.comName
Address
Phone
2102 Somerset Dr, Salt Lake Cty, UT 84121
Professional information
Dr. Joel S Bentz, Salt Lake City UT - MD (Doctor of Medicine)
Specialties:
Cytopathology
Address:
1950 Circle Of Hope Dr, Salt Lake City 84112
(801) 581-2507 (Phone)
ARUP Laboratories
500 Chipeta Way, Salt Lake City 84108
(801) 583-2787 (Phone)
50 N Medical Dr, Salt Lake City 84132
(801) 581-2507 (Phone)
(801) 581-2507 (Phone)
ARUP Laboratories
500 Chipeta Way, Salt Lake City 84108
(801) 583-2787 (Phone)
50 N Medical Dr, Salt Lake City 84132
(801) 581-2507 (Phone)
Certifications:
Anatomic & Clinical Pathology, 1995, Cytopathology, 1996
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1950 Circle Of Hope Dr, Salt Lake City 84112
50 N Medical Dr, Salt Lake City 84132
ARUP Laboratories
500 Chipeta Way, Salt Lake City 84108
University of Utah Health Care
50 North Medical Dr, Salt Lake City 84132
50 N Medical Dr, Salt Lake City 84132
ARUP Laboratories
500 Chipeta Way, Salt Lake City 84108
University of Utah Health Care
50 North Medical Dr, Salt Lake City 84132
Education:
Medical School
University Of North Dakota School Of Medicine
Graduated: 1990
University Nd School Med
Graduated: 1991
University Of Utah
Graduated: 1994
Hospital University Of Pennsylvania
Graduated: 1996
University Of North Dakota School Of Medicine
Graduated: 1990
University Nd School Med
Graduated: 1991
University Of Utah
Graduated: 1994
Hospital University Of Pennsylvania
Graduated: 1996
Fluorescent Cobalamins And Uses Thereof
US Patent:
2002019, Dec 19, 2002
Filed:
Mar 15, 2002
Appl. No.:
10/097646
Inventors:
Charles Grissom - Salt Lake City UT, US
Frederick West - Salt Lake City UT, US
James McGreevy - Salt Lake City UT, US
Joel Bentz - Salt Lake City UT, US
Michelle Cannon - Price UT, US
Frederick West - Salt Lake City UT, US
James McGreevy - Salt Lake City UT, US
Joel Bentz - Salt Lake City UT, US
Michelle Cannon - Price UT, US
International Classification:
C12Q001/68, C07H023/00
US Classification:
435/006000, 536/026440
Abstract:
The present invention relates to fluorescent cobalamins and uses of these compounds. More particularly, this invention relates to fluorescent cobalamins that comprise a fluorescent, phosphorescent, luminescent or light-producing compound covalently linked to cobalamin. These fluorescent cobalamins can be used to as diagnostic and prognostic markers (a) to distinguish cancer cells and tissues from healthy cells and tissues, including identifying lymph nodes containing cancer cells, and (b) to determine if an individual will respond positively to chemotherapy using cobalamin-therapeutic bioconjugates.
Fluorescent Cobalamins And Uses Thereof
US Patent:
6905884, Jun 14, 2005
Filed:
Jun 15, 2004
Appl. No.:
10/866988
Inventors:
Charles B. Grissom - Salt Lake City UT, US
Frederick G. West - Salt Lake City UT, US
James McGreevy - Salt Lake City UT, US
Joel S. Bentz - Salt Lake City UT, US
Michelle J. Cannon - Price UT, US
Frederick G. West - Salt Lake City UT, US
James McGreevy - Salt Lake City UT, US
Joel S. Bentz - Salt Lake City UT, US
Michelle J. Cannon - Price UT, US
Assignee:
University of Utah Research Foundation - Salt Lake City UT
International Classification:
G01N033/567, A61K031/70
US Classification:
436503, 514 52, 536 2644
Abstract:
The present invention relates to fluorescent cobalamins and uses of these compounds. More particularly, this invention relates to fluorescent cobalamins that comprise a fluorescent, phosphorescent, luminescent or light-producing compound covalently linked to cobalamin. These fluorescent cobalamins can be used to as diagnostic and prognostic markers (a) to distinguish cancer cells and tissues from healthy cells and tissues, including identifying lymph nodes containing cancer cells, and (b) to determine if an individual will respond positively to chemotherapy using cobalamin-therapeutic bioconjugates.